Dutasteride (0.5mg) + Tamsulosin (0.4mg)
Temsunir-D 0.4mg/0.5mg Tablet FC is used in the treatment of benign prostatic hyperplasia.
10 Tablet FC in 1 strip
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Temsunir-D 0.4mg/0.5mg Tablet FC may be taken with or without food, but it is better to take it at a fixed time.
Temsunir-D 0.4mg/0.5mg Tablet FC is a combination of two medicines: Tamsulosin and Dutasteride, which relieves the symptoms of benign prostatic hyperplasia. Tamsulosin is an alpha-blocker. It works by relaxing the muscle around the bladder exit and prostate gland so as to allow easy passage of urine. Dutasteride is a 5-alpha-reductase inhibitor which helps in shrinking the prostate by decreasing the level of the hormone which helps the prostate gland grow.
Related Warnings
Taking tamsulosin with alcohol may lower your blood pressure. This can cause dizziness or feeling like you might pass out, especially when getting up from a sitting or lying position.
Temsunir-D 0.4mg/0.5mg Tablet FC is highly unsafe to use during pregnancy.
Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.
No information is available on the use of Temsunir-D 0.4mg/0.5mg Tablet FC during lactation. Please consult your doctor.
Temsunir-D 0.4mg/0.5mg Tablet FC does not usually affect your ability to drive.
Temsunir-D 0.4mg/0.5mg Tablet FC is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Temsunir-D 0.4mg/0.5mg Tablet FC may not be needed in these patients. Please consult your doctor.
Temsunir-D 0.4mg/0.5mg Tablet FC should be used with caution in patients with liver disease. Dose adjustment of Temsunir-D 0.4mg/0.5mg Tablet FC may be needed. Please consult your doctor.
Use of Temsunir-D 0.4mg/0.5mg Tablet FC is not recommended in patients with severe liver disease.
